JMP Securities Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $21

Futu News02:31 · Ratings

Baird Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Cuts Target Price to $13

Futu NewsDec 18 00:31 · Ratings

Oppenheimer Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $26

Futu NewsDec 17 21:31 · Ratings

We're Hopeful That Larimar Therapeutics (NASDAQ:LRMR) Will Use Its Cash Wisely

Simply Wall StDec 17 21:04

A Quick Look at Today's Ratings for Larimar Therapeutics(LRMR.US), With a Forecast Between $14 to $36

Futu NewsDec 17 21:00 · Ratings

Larimar Therapeutics Announces Initial Data From OLE Study of Nomlabofusp

Yahoo FinanceDec 17 20:20